New diabetes clinical trial: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Published on: April 19, 2023 at 11:00AM
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Semaglutide Pen Injector; Drug: Placebo
Sponsors: University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
https://ift.tt/Qv2K8At
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Semaglutide Pen Injector; Drug: Placebo
Sponsors: University of Colorado, Denver; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
https://ift.tt/Qv2K8At
Comments
Post a Comment